GTG
Director Trades
| Date | Director | Value |
|---|
Company News
Market wrap: Australia bucks global trend as weak energy and miners deflate the ASX 200
Once again, Australia’s relative lack of technology stocks has seen the local market fail to keep pace with strong offshore leads. On Friday after all three major US equity benchmarks reset new highs, weakness in mining and energy stocks in Australia dragged the ASX 200 index down by 0.2% or 11.4 points, to 7770.6 points. […]
Genetic Technologies unveils GeneType test for unprecedented disease risk assessment
Molecular diagnostics company Genetic Technologies (ASX: GTG) has announced a major breakthrough in risk assessment tests for serious diseases. The new GeneType technology builds on the success of the company’s comprehensive hereditary breast and ovarian cancer test. The innovation will be a world first in identifying more than 200 high-penetrant genes to unlock the hereditary […]
Genetic Technologies to launch world-first comprehensive risk assessment test for breast and ovarian cancer
A ground-breaking comprehensive risk assessment test is set to be introduced by Genetic Technologies (ASX: GTG) to assesses the likelihood that a woman will develop breast and/or ovarian cancer, whether as a result of a hereditary genetic mutation or the much more prevalent familial or sporadic cancer. The test integrates Genetic Technologies’ patented and proprietary GeneType platform […]
ASX biotech stocks benefiting from the COVID-19 story
Normally investors shun speculative plays in times of market uncertainties, but that’s not been the case with ASX-listed life science stocks across the drug, diagnostics and device sectors. Naturally, the biotechs drawing a connection with fighting or detecting the virus – spurious or otherwise – have seen their valuations soar. Not that investor interest is […]
Genetic Technologies gets set for a temporary transition to mass-scale COVID-19 testing
Molecular diagnostics company Genetic Technologies (ASX: GTG) has thrown its weight towards mitigating the effects of COVID-19 by drafting a “detailed implementation plan” that could see its genetic testing facilities transformed into a high-throughput COVID-19 testing laboratory. In a statement to shareholders, Genetic said it has taken steps to enable a “temporary transition” of its facilities […]
Genetic Technologies launches two new early-warning cancer detection tests
Genetic risk assessment company Genetic Technologies (ASX: GTG) has unveiled two new ground-breaking cancer risk assessment tests for both colorectal and breast cancer. Branded as “GeneType for Colorectal Cancer” and “GeneType for Breast Cancer” the two tests combine information from genetic markers called “single nucleotide polymorphisms” to assess how people’s genetic make-up affects their risk of […]
Genetic Technologies partners with US research centre to commercialise polygenic risk tests
Genetic Technologies (ASX: GTG) has entered into an agreement with US-based Translational Genomics Research Institute (TGen) to develop and commercialise a suite of polygenic risks tests for the American market. While exact terms of the agreement are confidential, the companies disclosed today that they would work together to establish fundraising mechanisms needed to achieve the […]
Genetic Technologies taps China’s market with locally-based operation
Genetic risk assessment company Genetic Technologies (ASX: GTG) has officially established its Asia-based operations within China’s Hainan Resort Software Community Free Trade Zone – giving the company access to China’s US$925 billion healthcare market. In addition to having access to the China market, Genetic Technologies’ Hainan Resort-based operations will also receive assistance in obtaining China […]
Genetic Technologies casts BREVAGenplus into growing Chinese health market
Molecular diagnostics company Genetic Technologies (ASX: GTG) is following other industries into China’s flourishing health market with news it has signed a heads of agreement with Beijing Zishan Health. The blockchain-powered diagnostics company said it intends to explore opportunities to enter the Chinese market via an equally-split joint-venture agreement that will see Zishan marketing Genetic’s […]
Genetic Technologies works with University of Melbourne to expand breast cancer test to women with hereditary risk
Genetic Technologies (ASX: GTG) has struck an agreement with the University of Melbourne to enhance and broaden its genetic breast cancer risk assessment test to include women with a hereditary risk. The collaborative arrangement aims to assist physicians with more accurately predicting the risk in someone who has a strong family history of breast or […]